Cystatin C and the Risk for Cardiovascular Events in Patients With Asymptomatic Carotid Atherosclerosis | Zendy

Matthias Hoke | Zendy; Jasmin Amighi | Zendy; Wolfgang Mlekusch | Zendy; Oliver Schlager | Zendy; Markus Exner | Zendy; Schila Sabeti | Zendy; Petra Dick | Zendy; Renate Koppensteiner | Zendy; Erich Minar | Zendy; Holger Rumpold | Zendy; Oswald Wagner | Zendy; Martin Schillinger | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Cystatin C and the Risk for Cardiovascular Events in Patients With Asymptomatic Carotid Atherosclerosis

Author(s) -

Matthias Hoke,

Jasmin Amighi,

Wolfgang Mlekusch,

Oliver Schlager,

Markus Exner,

Schila Sabeti,

Petra Dick,

Renate Koppensteiner,

Erich Minar,

Holger Rumpold,

Oswald Wagner,

Martin Schillinger

Publication year - 2010

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.109.573162

Subject(s) - medicine , cystatin c , renal function , cardiology , asymptomatic , creatinine , myocardial infarction , hazard ratio , stroke (engine) , risk factor , confidence interval , mechanical engineering , engineering

Renal dysfunction is a risk factor for cardiovascular events in patients with atherosclerosis. Unlike serum creatinine or estimated glomerular filtration rate, cystatin C reflects renal dysfunction independent of factors such as sex, weight, and race. We investigated whether baseline serum levels of cystatin C predict major cardiovascular events in patients with asymptomatic carotid atherosclerosis and compared the predictive value of cystatin C to these established markers of renal function.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research